JP7589759B2 - 推定装置 - Google Patents

推定装置 Download PDF

Info

Publication number
JP7589759B2
JP7589759B2 JP2022579518A JP2022579518A JP7589759B2 JP 7589759 B2 JP7589759 B2 JP 7589759B2 JP 2022579518 A JP2022579518 A JP 2022579518A JP 2022579518 A JP2022579518 A JP 2022579518A JP 7589759 B2 JP7589759 B2 JP 7589759B2
Authority
JP
Japan
Prior art keywords
quality
culture
data
prediction
unit
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2022579518A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2022168774A5 (ja
JPWO2022168774A1 (https=
Inventor
崇 鈴木
周平 山本
健一 豊田
博隆 黒田
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shimadzu Corp
Original Assignee
Shimadzu Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shimadzu Corp filed Critical Shimadzu Corp
Publication of JPWO2022168774A1 publication Critical patent/JPWO2022168774A1/ja
Publication of JPWO2022168774A5 publication Critical patent/JPWO2022168774A5/ja
Application granted granted Critical
Publication of JP7589759B2 publication Critical patent/JP7589759B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16C—COMPUTATIONAL CHEMISTRY; CHEMOINFORMATICS; COMPUTATIONAL MATERIALS SCIENCE
    • G16C20/00—Chemoinformatics, i.e. ICT specially adapted for the handling of physicochemical or structural data of chemical particles, elements, compounds or mixtures
    • G16C20/30—Prediction of properties of chemical compounds, compositions or mixtures
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M41/00—Means for regulation, monitoring, measurement or control, e.g. flow regulation
    • C12M41/48—Automatic or computerized control
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16C—COMPUTATIONAL CHEMISTRY; CHEMOINFORMATICS; COMPUTATIONAL MATERIALS SCIENCE
    • G16C20/00—Chemoinformatics, i.e. ICT specially adapted for the handling of physicochemical or structural data of chemical particles, elements, compounds or mixtures
    • G16C20/70—Machine learning, data mining or chemometrics
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16C—COMPUTATIONAL CHEMISTRY; CHEMOINFORMATICS; COMPUTATIONAL MATERIALS SCIENCE
    • G16C20/00—Chemoinformatics, i.e. ICT specially adapted for the handling of physicochemical or structural data of chemical particles, elements, compounds or mixtures
    • G16C20/80—Data visualisation

Landscapes

  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Computing Systems (AREA)
  • Theoretical Computer Science (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Data Mining & Analysis (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Medical Informatics (AREA)
  • Software Systems (AREA)
  • Evolutionary Computation (AREA)
  • Toxicology (AREA)
  • General Physics & Mathematics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Databases & Information Systems (AREA)
  • Computer Vision & Pattern Recognition (AREA)
  • Artificial Intelligence (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
JP2022579518A 2021-02-08 2022-01-31 推定装置 Active JP7589759B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2021017968 2021-02-08
JP2021017968 2021-02-08
PCT/JP2022/003522 WO2022168774A1 (ja) 2021-02-08 2022-01-31 推定装置、学習装置、最適化装置、推定方法、学習方法、および最適化方法

Publications (3)

Publication Number Publication Date
JPWO2022168774A1 JPWO2022168774A1 (https=) 2022-08-11
JPWO2022168774A5 JPWO2022168774A5 (ja) 2023-10-25
JP7589759B2 true JP7589759B2 (ja) 2024-11-26

Family

ID=82741392

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022579518A Active JP7589759B2 (ja) 2021-02-08 2022-01-31 推定装置

Country Status (5)

Country Link
US (1) US20240120033A1 (https=)
EP (1) EP4290523A4 (https=)
JP (1) JP7589759B2 (https=)
CN (1) CN116830204B (https=)
WO (1) WO2022168774A1 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12587274B2 (en) 2023-03-28 2026-03-24 Quantum Generative Materials Llc Satellite optimization management system based on natural language input and artificial intelligence
WO2024203378A1 (ja) * 2023-03-31 2024-10-03 ソニーグループ株式会社 細胞処理システム、細胞処理方法および学習装置
WO2024252556A1 (ja) * 2023-06-07 2024-12-12 日本電信電話株式会社 最適化システム、最適化装置、最適化方法およびプログラム
US12368503B2 (en) 2023-12-27 2025-07-22 Quantum Generative Materials Llc Intent-based satellite transmit management based on preexisting historical location and machine learning
US12603701B2 (en) 2023-12-27 2026-04-14 Quantum Generative Materials Llc Distributed satellite constellation management and control system

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009044974A (ja) 2007-08-16 2009-03-05 Univ Nagoya 細胞の品質を予測する予測モデルの構築法、予測モデルの構築用ブログラム、該プログラムを記録した記録媒体、予測モデルの構築用装置
US20140322699A1 (en) 2013-03-15 2014-10-30 Genzyme Corporation Affinity-Based Analytical Purification Of Biotherapeutics For Bioprocess Monitoring
JP2019110767A (ja) 2017-12-20 2019-07-11 株式会社日立製作所 細胞培養装置の制御方法及び制御システム
US20190272894A1 (en) 2018-03-02 2019-09-05 Genzyme Corporation Multivariate Spectral Analysis and Monitoring for Biomanufacturing
WO2020021860A1 (ja) 2018-07-24 2020-01-30 富士フイルム株式会社 細胞培養支援装置の作動プログラム、細胞培養支援装置、細胞培養支援装置の作動方法
WO2020039683A1 (ja) 2018-08-22 2020-02-27 富士フイルム株式会社 細胞培養支援装置の作動プログラム、細胞培養支援装置、細胞培養支援装置の作動方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA05006522A (es) 2002-12-23 2006-02-17 Bristol Myers Squibb Co Mejora en la calidad de producto en procesos de cultivo en celulas de mamiferos para la produccion de proteina.
DE102005027906B4 (de) * 2005-02-09 2013-06-06 EloSystems Dr. Angersbach & Dr. Bunin GbR (vertretungsberechtigter Gesellschafter Herr Dr. Alexander Angersbach, 13599 Berlin) Verfahren zur zeitnahen Erkennung und Vorhersage der Zustandsentwicklung von Zellsuspensionen und/oder zur Optimierung und Steuerung von biotechnologischen Prozessen
US10214718B2 (en) * 2013-07-01 2019-02-26 University Of Massachusetts Distributed perfusion bioreactor system for continuous culture of biological cells
KR102344339B1 (ko) * 2016-04-04 2021-12-28 베링거 인겔하임 에르체파우 게엠베하 운트 코 카게 제제 정제의 실시간 모니터링
EP3548900B1 (en) * 2016-12-02 2023-12-27 Roche Diagnostics GmbH Failure state prediction for automated analyzers for analyzing a biological sample
JP7279026B2 (ja) * 2017-09-20 2023-05-22 メルサナ セラピューティクス インコーポレイテッド Ｎａｐｉ２ｂ標的化療法に対する応答を予測するための組成物および方法
AU2018350890B2 (en) * 2017-10-16 2024-07-04 Regeneron Pharmaceuticals, Inc. In situ Raman spectroscopy systems and methods for controlling process variables in cell cultures
CA3083124A1 (en) * 2017-11-20 2019-05-23 Lonza Ltd. Process and system for propagating cell cultures while preventing lactate accumulation
JP7092879B2 (ja) * 2017-12-29 2022-06-28 エフ．ホフマン－ラ ロシュ アーゲー 細胞培養物の代謝状態の予測
EP3938540A4 (en) * 2019-03-15 2022-12-14 The Trustees of Columbia University in the City of New York SEQUENCING DATA ANALYSIS SYSTEMS AND METHODS
JP7562563B2 (ja) * 2019-04-30 2024-10-07 アムジエン・インコーポレーテツド バイオ医薬品生産における細胞株選択のためのデータ駆動予測モデリング
CN112017730B (zh) * 2020-08-26 2022-08-09 深圳太力生物技术有限责任公司 基于表达量预测模型的细胞筛选方法和装置

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009044974A (ja) 2007-08-16 2009-03-05 Univ Nagoya 細胞の品質を予測する予測モデルの構築法、予測モデルの構築用ブログラム、該プログラムを記録した記録媒体、予測モデルの構築用装置
US20140322699A1 (en) 2013-03-15 2014-10-30 Genzyme Corporation Affinity-Based Analytical Purification Of Biotherapeutics For Bioprocess Monitoring
JP2019110767A (ja) 2017-12-20 2019-07-11 株式会社日立製作所 細胞培養装置の制御方法及び制御システム
US20190272894A1 (en) 2018-03-02 2019-09-05 Genzyme Corporation Multivariate Spectral Analysis and Monitoring for Biomanufacturing
WO2020021860A1 (ja) 2018-07-24 2020-01-30 富士フイルム株式会社 細胞培養支援装置の作動プログラム、細胞培養支援装置、細胞培養支援装置の作動方法
WO2020039683A1 (ja) 2018-08-22 2020-02-27 富士フイルム株式会社 細胞培養支援装置の作動プログラム、細胞培養支援装置、細胞培養支援装置の作動方法

Also Published As

Publication number Publication date
CN116830204B (zh) 2026-04-14
JPWO2022168774A1 (https=) 2022-08-11
EP4290523A1 (en) 2023-12-13
CN116830204A (zh) 2023-09-29
EP4290523A4 (en) 2025-11-26
US20240120033A1 (en) 2024-04-11
WO2022168774A1 (ja) 2022-08-11

Similar Documents

Publication Publication Date Title
JP7589759B2 (ja) 推定装置
US12584091B2 (en) Predicting the metabolic condition of a cell culture
US12182482B2 (en) Method for predicting outcome of an modelling of a process in a bioreactor
JP2025000734A (ja) バイオ医薬品生産における細胞株選択のためのデータ駆動予測モデリング
JPWO2022168774A5 (ja) 推定装置
US20250315014A1 (en) Multivariate process chart to control a process to produce a chemical, pharmaceutical, biopharmaceutical and/or biological product
JP7153131B2 (ja) 培養装置の性能を検証する方法
JP7207643B2 (ja) 連続培養条件のスクリーニング方法
US12422803B2 (en) Optimized process control
Bickle High-content screening: a new primary screening tool?
EP4226222A1 (en) Method and system for predicting the performance of biopharmaceutical manufacturing processes
Behdani et al. Rapid total sialic acid monitoring during cell culture process using a machine learning model based soft sensor
WO2021110520A1 (en) Adapting control of a cell culture in a production scale vessel with regard to a starting medium
HK40036640B (zh) 细胞培养物的代谢状态的预测
HK40050188A (en) Method for verifying cultivation device performance
Heins Bioprocess Monitoring: How Much Do We Need to Know for Successful Scale-Up?
WO2022239535A1 (ja) 抗体生成支援方法、および抗体生成支援用プログラム
Crowell Computational Techniques for Proteome and Genome Wide Circadian Studies
WO2026024761A1 (en) Scalable closed-loop bio-manufacturing of tumor models or other volumetric biological samples
WO2022066418A1 (en) Methods and systems for determining a minimum number of cell line clones necessary to produce a product having a set of target product attributes
Heins Bioprocess Monitoring: How Much Do
Waldschitz Model development and comparison of mechanistic models for E. coli to allow for model predictive control
Shai Prasanna et al. Multi-Environment Trials and G× E Interaction Analysis

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20230714

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20230714

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20240423

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20240619

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20240708

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20240827

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20241002

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20241015

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20241028

R150 Certificate of patent or registration of utility model

Ref document number: 7589759

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150